Literature DB >> 19868166

THE PRODUCTION OF ANTIPNEUMOCOCCIC SERUM.

R Cole1, H F Moore.   

Abstract

In the production of immune serum for therapeutic purposes strict attention must be paid to the immunological specificity of the bacteria used for immunization. At present the only serum of which the therapeutic value has been proven is that effective against Type I pneumococcus infection. This serum should have agglutinating power for Type I pneumococcus and should have the power of protecting mice against large amounts of virulent culture. Experiments have shown that for producing the primary immunity most rapidly several series of small doses of dead cultures should be given, the injections being made daily for 6 to 7 days, followed by a week in which no injections are made. To produce the highest type of immunity probably living organisms are required. These should be given in moderate doses daily for 3 days, with an interval of a week between each series of injections. By following accurately the methods described, horses may be made to produce rapidly a high grade of specific serum. The observations so far made indicate the importance of employing small doses of culture frequently repeated in this form of immunization.

Entities:  

Year:  1917        PMID: 19868166      PMCID: PMC2125795          DOI: 10.1084/jem.26.4.537

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  8 in total

1.  CONCENTRATION OF THE PROTECTIVE BODIES IN ANTIPNEUMOCOCCUS SERUM BY MEANS OF SPECIFIC PRECIPITATION.

Authors:  F P Gay; H T Chickering
Journal:  J Exp Med       Date:  1915-04-01       Impact factor: 14.307

2.  METHODS FOR THE DETERMINATION OF PNEUMOCOCCUS TYPES.

Authors:  F G Blake
Journal:  J Exp Med       Date:  1917-07-01       Impact factor: 14.307

3.  AN IMMUNOLOGICAL STUDY OF PNEUMOCOCCUS MUCOSUS.

Authors:  F M Hanes
Journal:  J Exp Med       Date:  1914-01-01       Impact factor: 14.307

4.  THE RAPID PRODUCTION OF ANTIDYSENTERIC SERUM.

Authors:  S Flexner; H L Amoss
Journal:  J Exp Med       Date:  1915-05-01       Impact factor: 14.307

5.  A METHOD FOR THE RAPID PREPARATION OF ANTIMENINGITIS SERUM.

Authors:  H L Amoss; M Wollstein
Journal:  J Exp Med       Date:  1916-03-01       Impact factor: 14.307

6.  IMMUNITY FACTORS IN PNEUMOCOCCUS INFECTION IN THE DOG.

Authors:  C G Bull
Journal:  J Exp Med       Date:  1916-07-01       Impact factor: 14.307

7.  STUDIES ON PNEUMOCOCCUS INFECTION IN ANIMALS : SECOND PAPER: ACTION OF IMMUNE SERA ON PNEUMOCOCCUS INFECTION.

Authors:  A B Wadsworth
Journal:  J Exp Med       Date:  1912-07-01       Impact factor: 14.307

8.  THE LATENT PERIOD IN THE GROWTH OF BACTERIA.

Authors:  A M Chesney
Journal:  J Exp Med       Date:  1916-10-01       Impact factor: 14.307

  8 in total
  19 in total

1.  PNEUMONIA AND ITS SERUM TREATMENT.

Authors: 
Journal:  Br Med J       Date:  1918-01-12

2.  SEROLOGICAL RELATIONSHIPS OF TYPE-SPECIFIC AND DEGRADED PNEUMOCOCCI.

Authors:  H A Reimann
Journal:  J Exp Med       Date:  1926-01-01       Impact factor: 14.307

3.  THE IDENTITY OF THE MECHANISMS OF TYPE-SPECIFIC AGGLUTININ AND PRECIPITIN REACTIONS WITH PNEUMOCOCCUS.

Authors:  T Francis
Journal:  J Exp Med       Date:  1932-01-01       Impact factor: 14.307

4.  THE ANTIGENIC PROPERTIES OF SOLUTIONS OF PNEUMOCOCCUS.

Authors:  O T Avery; J M Neill
Journal:  J Exp Med       Date:  1925-08-31       Impact factor: 14.307

5.  THE INTERCONVERTIBILITY OF "R" AND "S" FORMS OF PNEUMOCOCCUS.

Authors:  M H Dawson
Journal:  J Exp Med       Date:  1928-03-31       Impact factor: 14.307

6.  FACTORS INVOLVED IN THE PRODUCTION OF IMMUNITY WITH PNEUMOCOCCUS VACCINE : I. ACTIVE AND PASSIVE IMMUNITY DURING THE FIRST SEVEN DAYS AFTER INJECTION OF ANTIGEN.

Authors:  A L Barach
Journal:  J Exp Med       Date:  1928-06-30       Impact factor: 14.307

7.  IMMUNOLOGICAL PROPERTIES OF A TYPICAL (S-PRODUCING) AND A DEGRADED (NON-S-PRODUCING) STRAIN OF TYPE II PNEUMOCOCCUS WITH SPECIAL REFERENCE TO PROTECTIVE ANTIBODIES.

Authors:  E L Gaspari; W L Fleming; J M Neill
Journal:  J Exp Med       Date:  1927-06-30       Impact factor: 14.307

8.  A COMPARISON OF THE EFFECTS OF X-RAY AND DRY HEAT ON ANTIBODY FORMATION.

Authors:  J B Murphy; E Sturm
Journal:  J Exp Med       Date:  1925-01-31       Impact factor: 14.307

9.  ACTIVE AND PASSIVE IMMUNITY TO PNEUMOCOCCUS INFECTION INDUCED IN RABBITS BY IMMUNIZATION WITH R PNEUMOCOCCI.

Authors:  W S Tillett
Journal:  J Exp Med       Date:  1928-11-30       Impact factor: 14.307

10.  A COMPARATIVE STUDY OF SMOOTH AND ROUGH PNEUMOCOCCUS COLONIES.

Authors:  J R Paul
Journal:  J Exp Med       Date:  1927-10-31       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.